Celltrion received marketing authorization of 'Remsima' in the Japanese MHLW

On July 4, Celltrion announced that they received marketing authorization of 'Remsima' in the Japanese MHLW( Ministry of Health, labour and Welfare).

According to Celltrion, they applied for marketing approval of Remsima in PMDA (Pharmaceuticals and Medical Devices Agency, Japan) on last September. It is expected to begin selling in earnest in Japan through co-developer Nippon Kayaku starting ...